The Results of Pars Plana Vitrectomy in Diabetic Macular Edema

Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection

NCT03453281 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membrane

NCT05529589 ·Status: UNKNOWN

Triple Therapy for Diffuse Diabetic Macular Edema

NCT01218750 ·Status: UNKNOWN ·Phase: NA

Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept

NCT05610488 ·Status: UNKNOWN ·Phase: PHASE4

Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema

NCT03603990 ·Status: WITHDRAWN ·Phase: NA

Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage

NCT04153253 ·Status: COMPLETED ·Phase: PHASE4

Autofluorescence in Uveitic and Diabetic Macular Edema

NCT00956124 ·Status: WITHDRAWN

Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections

NCT01769599 ·Status: UNKNOWN

Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema

NCT00371410 ·Status: COMPLETED ·Phase: PHASE1

Intravitreal Aflibercept Injection in Vision Impairment Due to DME

NCT01331681 ·Status: COMPLETED ·Phase: PHASE3

Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery

NCT01988246 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane

NCT02995746 ·Status: TERMINATED ·Phase: NA

Diabetic Retinopathy Assessed by Ultra-wide

NCT03157206 ·Status: UNKNOWN

Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema

NCT01824862 ·Status: COMPLETED

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

NCT03437551 ·Status: COMPLETED

Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography

NCT03783832 ·Status: UNKNOWN

Visual Function, Center Point Thickness and Macular Volume After Photocoagulation

NCT00906659 ·Status: COMPLETED

Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection

NCT03297684 ·Status: UNKNOWN

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

NCT01790945 ·Status: UNKNOWN

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

NCT00600301 ·Status: WITHDRAWN ·Phase: PHASE3

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

NCT06879301 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

NCT02850263 ·Status: COMPLETED

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

NCT00799227 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema

NCT00069056 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement

NCT01783886 ·Status: COMPLETED ·Phase: PHASE3